ARTICLE | Clinical News
Surfaxin lucinactant: Phase Ib
December 13, 1999 8:00 AM UTC
DSCO published in the American Journal of Respiratory and Critical Care Medicine results of a 12-patient Phase Ib trial showing that Surfaxin lavage was tolerated with no serious adverse events. Measu...